Log In
BCIQ
Print this Print this
 

XN001

  Manage Alerts
Collapse Summary General Information
Company XoNovo Ltd.
DescriptionSmall molecule derivative of lanthionine ketimine
Molecular Target Collapsin response mediator protein-2 (DPYSL2) (CRMP-2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Neurology (unspecified)
Indication DetailsTreat Batten disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today